BridgeMD
Tests treatment safety and results for Intra and Postoperative Pain Management
Official title The Analgesic Efficacy of Perineural Nalbuphine as an Adjuvant to Bupivacaine in Ultrasound Guided Superficial Cervical Plexus Nerve Block for Thyroid Surgeries. A Double Blinded Randomized Controlled Trial.
ClinicalTrials.gov ID: NCT06633068
What this study is testing
What is Adding perineural Nalbuphine to Bupivacaine in superficial cervical nerve block?
Adding perineural Nalbuphine to Bupivacaine in superficial cervical nerve block is an investigational medicine, being studied as a potential treatment for intra and postoperative pain management.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aiming to evaluate the analgesic effect of adding nalbuphine as an adjuvant to bupivacaine in superficial cervical plexus block during thyroid surgeries regarding first rescue analgesia in the first twenty-four hours postoperative, VAS score after extubation and complications such as postoperative nausea, vomiting and respiratory depression.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Patients aged between 18 to 60 years old of both sexes undergoing elective thyroid surgery.
- ASA I and II.
You likely can't join if
- Patient refusal.
- Hypersensitivity or contraindication to nalbuphine or bupivacaine.
- Pregnancy or lactating mothers.
- Hepatic, cardiac or renal diseases.
- Bleeding disorders.
- Severe neurological or psychological disorders.
See the full eligibility criteria
- Patients aged between 18 to 60 years old of both sexes undergoing elective thyroid surgery.
- ASA I and II.
- Patient refusal.
- Hypersensitivity or contraindication to nalbuphine or bupivacaine.
- Pregnancy or lactating mothers.
- Hepatic, cardiac or renal diseases.
- Bleeding disorders.
- Severe neurological or psychological disorders.
- Goitres with retrosternal extension.
- Any anatomical disruption in the neck (ex: metastatic lymph nodes).
The study team makes the final eligibility decision.
Where it's taking place
- Giza, الجيزة, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Giza, الجيزة, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.